Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children

NCT04569357 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT04569357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04569357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Prospekta in the Treatment of Attention Deficit/Hyperactivity Disorder in Children
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Completed
Start date
November 20, 2020
Completion date
February 18, 2022
Enrollment
363 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder